<DOC>
	<DOCNO>NCT00870558</DOCNO>
	<brief_summary>RATIONALE : Iodine I 131 ethiodized oil may help prevent delay recurrence cancer . It yet know whether iodine I 131 ethiodized oil effective non-radiolabeled ethiodized oil prevent recurrent cancer patient undergone treatment liver cancer . PURPOSE : This randomized phase III trial study iodine I 131 ethiodized oil see well work compare non-radiolabeled ethiodized oil prevent recurrent cancer patient undergone treatment liver cancer .</brief_summary>
	<brief_title>Iodine I 131 Ethiodized Oil Preventing Recurrent Cancer Patients Who Have Undergone Treatment Liver Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine whether treatment adjuvant intra-arterial iodine I 131 ethiodized oil reduces percentage tumor recurrence patient curatively treat hepatocellular carcinoma . Secondary - Evaluate overall recurrence-free survival patient . - Evaluate deterioration liver function patient . - Evaluate toxicity intra-arterial iodine I 131 ethiodized oil patient . OUTLINE : This multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive intra-arterial infusion iodine I 131 ethiodized oil . - Arm II : Patients receive intra-arterial infusion unlabeled ethiodized oil . After completion study treatment , patient follow periodically 5 year .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<mesh_term>Ethiodized Oil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis hepatocellular carcinoma ( HCC ) Alphafetoprotein &lt; 20 ng/mL Must undergone curative treatment HCC within past 820 week , include 1 following : Curative resection Alcohol ablation , radiofrequency ablation , cryotherapy ( 1 2 nodule &lt; 5 cm diameter ) No ascites No intrahepatic involvement nodule progression assess ultrasound No extrahepatic metastasis PATIENT CHARACTERISTICS : WHO performance status 02 ANC ≥ 1,500/mm³ Platelet count ≥ 50,000/mm³ Bilirubin ≤ 51 μmol/L Creatinine ≤ 120 μmol/L Not pregnant nursing Negative pregnancy test ChildPugh score &lt; 8 ( class B ) No decompensated cirrhosis No encephalopathy No uncontrolled bleed No portal thrombosis , right leftbranch thrombosis , extrahepatic thrombosis , portal reflux doppler CT scan No unstable medical surgical disease No contraindication vascular arteriography No history complication injection iodine contrast agent Not incarcerate PRIOR CONCURRENT THERAPY : See Disease Characteristics Recovered prior therapy No prior hormonal treatment , include tamoxifen somatostatin analogs No prior systemic chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>adult primary hepatocellular carcinoma</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>localize resectable adult primary liver cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
</DOC>